These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
610 related articles for article (PubMed ID: 29917175)
1. [Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL)]. Hedén P; Stark B Lakartidningen; 2018 Jun; 115():. PubMed ID: 29917175 [TBL] [Abstract][Full Text] [Related]
2. UK Guidelines on the Diagnosis and Treatment of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) on behalf of the Medicines and Healthcare products Regulatory Agency (MHRA) Plastic, Reconstructive and Aesthetic Surgery Expert Advisory Group (PRASEAG). Turton P; El-Sharkawi D; Lyburn I; Sharma B; Mahalingam P; Turner SD; MacNeill F; Johnson L; Hamilton S; Burton C; Mercer N J Plast Reconstr Aesthet Surg; 2021 Jan; 74(1):13-29. PubMed ID: 33483089 [TBL] [Abstract][Full Text] [Related]
3. Breast implant associated anaplastic large cell lymphoma: The UK experience. Recommendations on its management and implications for informed consent. Johnson L; O'Donoghue JM; McLean N; Turton P; Khan AA; Turner SD; Lennard A; Collis N; Butterworth M; Gui G; Bristol J; Hurren J; Smith S; Grover K; Spyrou G; Krupa K; Azmy IA; Young IE; Staiano JJ; Khalil H; MacNeill FA Eur J Surg Oncol; 2017 Aug; 43(8):1393-1401. PubMed ID: 28596034 [TBL] [Abstract][Full Text] [Related]
4. Breast implant-associated ALK-negative anaplastic large cell lymphoma: a case report and discussion of possible pathogenesis. George EV; Pharm J; Houston C; Al-Quran S; Brian G; Dong H; Hai W; Reeves W; Yang LJ Int J Clin Exp Pathol; 2013; 6(8):1631-42. PubMed ID: 23923082 [TBL] [Abstract][Full Text] [Related]
5. Breast Implant-Associated Anaplastic Large Cell Lymphoma: Defining Future Research Priorities. DeCoster RC; Lynch EB; Bonaroti AR; Miranda RN; Hunt KK; Clemens MW Clin Plast Surg; 2021 Jan; 48(1):33-43. PubMed ID: 33220903 [TBL] [Abstract][Full Text] [Related]
6. Breast Reconstruction Following Breast Implant-Associated Anaplastic Large Cell Lymphoma. Lamaris GA; Butler CE; Deva AK; Miranda RN; Hunt KK; Connell T; Lipa JE; Clemens MW Plast Reconstr Surg; 2019 Mar; 143(3S A Review of Breast Implant-Associated Anaplastic Large Cell Lymphoma):51S-58S. PubMed ID: 30817556 [TBL] [Abstract][Full Text] [Related]
7. Breast implant-associated anaplastic large cell lymphoma - From diagnosis to treatment. Kaartinen I; Sunela K; Alanko J; Hukkinen K; Karjalainen-Lindsberg ML; Svarvar C Eur J Surg Oncol; 2017 Aug; 43(8):1385-1392. PubMed ID: 28625797 [TBL] [Abstract][Full Text] [Related]
8. Is breast implant-associated anaplastic large cell lymphoma a hazard of breast implant surgery? Fitzal F; Turner SD; Kenner L Open Biol; 2019 Apr; 9(4):190006. PubMed ID: 30939983 [TBL] [Abstract][Full Text] [Related]
9. Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL): an overview of presentation and pathogenesis and guidelines for pathological diagnosis and management. Jones JL; Hanby AM; Wells C; Calaminici M; Johnson L; Turton P; Deb R; Provenzano E; Shaaban A; Ellis IO; Pinder SE; Histopathology; 2019 Dec; 75(6):787-796. PubMed ID: 31166611 [TBL] [Abstract][Full Text] [Related]
10. Best Practices Guideline for the Pathologic Diagnosis of Breast Implant-Associated Anaplastic Large-Cell Lymphoma. Jaffe ES; Ashar BS; Clemens MW; Feldman AL; Gaulard P; Miranda RN; Sohani AR; Stenzel T; Yoon SW J Clin Oncol; 2020 Apr; 38(10):1102-1111. PubMed ID: 32045544 [TBL] [Abstract][Full Text] [Related]
11. Biomarkers Provide Clues to Early Events in the Pathogenesis of Breast Implant-Associated Anaplastic Large Cell Lymphoma. Kadin ME; Deva A; Xu H; Morgan J; Khare P; MacLeod RA; Van Natta BW; Adams WP; Brody GS; Epstein AL Aesthet Surg J; 2016 Jul; 36(7):773-81. PubMed ID: 26979456 [TBL] [Abstract][Full Text] [Related]
12. Does Breast Implant-Associated ALCL Begin as a Lymphoproliferative Disorder? Kadin ME; Adams WP; Inghirami G; Di Napoli A Plast Reconstr Surg; 2020 Jan; 145(1):30e-38e. PubMed ID: 31577659 [TBL] [Abstract][Full Text] [Related]
13. An Unusual Case of BIA-ALCL Associated with Prolonged/Complicated Biocell-Textured Expander, followed by Smooth Round Breast Implant Exposure, and Concurrent Use of Adalimumab. Akhavan AA; Wirtz EC; Ollila DW; Bhatt N Plast Reconstr Surg; 2021 Aug; 148(2):299-303. PubMed ID: 34133406 [TBL] [Abstract][Full Text] [Related]
14. Anaplastic Large-Cell Lymphoma Associated with Breast Implants: A Case Report of a Transgender Female. Patzelt M; Zarubova L; Klener P; Barta J; Benkova K; Brandejsova A; Trneny M; Gürlich R; Sukop A Aesthetic Plast Surg; 2018 Apr; 42(2):451-455. PubMed ID: 29101436 [TBL] [Abstract][Full Text] [Related]
15. Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) and the Textured Breast Implant Crisis. K Groth A; Graf R Aesthetic Plast Surg; 2020 Feb; 44(1):1-12. PubMed ID: 31624894 [TBL] [Abstract][Full Text] [Related]
16. Breast implant associated anaplastic large cell lymphoma: a case report and reconstructive option. De Silva IM; Teague JA; Blake WE J Plast Reconstr Aesthet Surg; 2013 Dec; 66(12):1773-6. PubMed ID: 23751975 [TBL] [Abstract][Full Text] [Related]
17. Breast Implant-Associated Anaplastic Large Cell Lymphoma: Immediate or Delayed Implant Replacement? Shine JJ; Boghossian E; Beauchemin G; Papanastasiou VW; Borsuk DE Aesthetic Plast Surg; 2018 Dec; 42(6):1492-1498. PubMed ID: 30094550 [TBL] [Abstract][Full Text] [Related]
18. Breast implant-associated anaplastic large cell lymphoma: review of a distinct clinicopathologic entity. Xu J; Wei S Arch Pathol Lab Med; 2014 Jun; 138(6):842-6. PubMed ID: 24878027 [TBL] [Abstract][Full Text] [Related]
19. Breast implant-associated anaplastic large cell lymphoma: A comprehensive review. Marra A; Viale G; Pileri SA; Pravettoni G; Viale G; De Lorenzi F; Nolè F; Veronesi P; Curigliano G Cancer Treat Rev; 2020 Mar; 84():101963. PubMed ID: 31958739 [TBL] [Abstract][Full Text] [Related]
20. UK Guidelines on the Diagnosis and Treatment of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) on behalf of the Medicines and Healthcare products Regulatory Agency (MHRA) Plastic, Reconstructive and Aesthetic Surgery Expert Advisory Group (PRASEAG). Turton P; El-Sharkawi D; Lyburn I; Sharma B; Mahalingam P; Turner SD; MacNeill F; Johnson L; Hamilton S; Burton C; Mercer N Eur J Surg Oncol; 2021 Feb; 47(2):199-210. PubMed ID: 33358076 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]